1. Acknowledgment

   Announcement 16 August 2012 Pages: 343 - 344

2. Tumor Necrosis Factor- α

   • Enrico Heffler
   • Mike Berry
   • Ian D. Pavord

   Current Opinion 16 August 2012 Pages: 345 - 349

   

3. Biosimilar Drugs

   • Armando A. Genazzani
   • Giovanni Biggio
   • Pier Luigi Canonico

   Current Opinion 16 August 2012 Pages: 351 - 356

   

4. Progress and Challenges towards the Development of Malaria Vaccines

   • Kevin K.A. Tetteh
   • Spencer D. Polley

   Drug Development 16 August 2012 Pages: 357 - 373

   

5. Anticancer Therapy Targeting Telomeres and Telomerase

   • E. Kenneth Parkinson
   • Fay Minty

   Mechanisms and Targets 16 August 2012 Pages: 375 - 385

   

6. Therapeutic Applications of Synthetic CpG Oligodeoxynucleotides as TLR9 Agonists for Immune Modulation

   • Marion Jurk
   • Jörg Vollmer

   Mechanisms and Targets 16 August 2012 Pages: 387 - 401

   

7. The Role of Anti-IgE Therapy in Combination with Allergen Specific Immunotherapy for Seasonal Allergic Rhinitis

   • Philippe Stock
   • Claudia Rolinck-Werninghaus
   • Eckard Hamelmann

   Novel Therapeutic Strategies 16 August 2012 Pages: 403 - 410